![Giovanni de Castro](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Giovanni de Castro
Technik-/Wissenschafts-/F&E-Leiter bei Melt Pharmaceuticals, Inc.
Aktive Positionen von Giovanni de Castro
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Melt Pharmaceuticals, Inc.
![]() Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2021 | - |
Karriereverlauf von Giovanni de Castro
Statistik
International
Vereinigte Staaten | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Melt Pharmaceuticals, Inc.
![]() Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN. | Health Technology |
- Börse
- Insiders
- Giovanni de Castro
- Erfahrung